Neoadjuvant chemotherapy for borderline resectable and...

Neoadjuvant chemotherapy for borderline resectable and resectable pancreatic adenocarcinoma: single agent gemcitabine may not be inferior to multi-agent chemotherapy

Kizy, S., Altman, A., Hui, J.Y.C., Tuttle, T., Marmor, S., Lou, E., Greeno, E., Chang, K., Denbo, J.W., Jensen, E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Journal:
HPB
DOI:
10.1016/j.hpb.2018.06.2052
Date:
September, 2018
File:
PDF, 46 KB
2018
Conversion to is in progress
Conversion to is failed